{"result": "(\"entity\"<|>KOREAN CIRCULATION JOURNAL<|>ORGANIZATION<|>The Korean Circ J is a medical journal that publishes research related to cardiovascular health and diseases.)\n##\n(\"entity\"<|>DASH-SODIUM COLLABORATIVE RESEARCH GROUP<|>ORGANIZATION<|>The DASH-Sodium Collaborative Research Group is a research group focused on dietary approaches to manage hypertension.)\n##\n(\"entity\"<|>LANCET<|>ORGANIZATION<|>The Lancet is a leading medical journal that publishes high-quality research and reviews in the field of medicine.)\n##\n(\"entity\"<|>CANCER RESEARCH<|>ORGANIZATION<|>Cancer Research is a journal that publishes research articles related to cancer prevention, diagnosis, and treatment.)\n##\n(\"entity\"<|>NATIONAL CANCER INSTITUTE<|>ORGANIZATION<|>The National Cancer Institute is a part of the U.S. National Institutes of Health and is the federal government's principal agency for cancer research and training.)\n##\n(\"entity\"<|>NORWEGIAN WOMEN AND CANCER STUDY<|>EVENT<|>The Norwegian Women and Cancer Study is a prospective cohort study investigating the relationship between diet and cancer risk among Norwegian women.)\n##\n(\"entity\"<|>CANCER EPIDEMIOLOGY BIOMARKERS AND PREVENTION<|>ORGANIZATION<|>Cancer Epidemiol Biomarkers Prev is a journal that focuses on the epidemiology of cancer and the biomarkers that can be used for prevention and early detection.)\n##\n(\"entity\"<|>JOURNAL OF CLINICAL HYPERTENSION<|>ORGANIZATION<|>The Journal of Clinical Hypertension publishes research on hypertension and related cardiovascular diseases.)\n##\n(\"entity\"<|>CANCER CAUSES AND CONTROL<|>ORGANIZATION<|>Cancer Causes and Control is a journal that publishes research on the causes of cancer and the factors that influence cancer control.)\n##\n(\"entity\"<|>JOURNAL OF NATURAL CANCER INSTITUTE<|>ORGANIZATION<|>The Journal of Natural Cancer Institute publishes research on cancer biology, prevention, and treatment.)\n##\n(\"entity\"<|>CURRENT PHARMACEUTICAL DESIGN<|>ORGANIZATION<|>Current Pharm Des is a journal that publishes articles on the design and development of new pharmaceuticals.)\n##\n(\"entity\"<|>CANCER STATISTICS<|>EVENT<|>Cancer Statistics is an annual report that provides an overview of cancer incidence, mortality, and survival statistics in the United States.)\n##\n(\"entity\"<|>CANCER EPIDEMIOLOGY<|>ORGANIZATION<|>Cancer Epidemiology is a journal that focuses on the epidemiology of cancer and its risk factors.)\n##\n(\"relationship\"<|>DASH-SODIUM COLLABORATIVE RESEARCH GROUP<|>JOURNAL OF CLINICAL HYPERTENSION<|>The DASH-Sodium Collaborative Research Group's findings are published in the Journal of Clinical Hypertension, indicating a direct relationship between their research and the journal<|>8)\n##\n(\"relationship\"<|>NORWEGIAN WOMEN AND CANCER STUDY<|>CANCER CAUSES AND CONTROL<|>The Norwegian Women and Cancer Study is published in Cancer Causes and Control, showing a relationship between the study and the journal<|>7)\n##\n(\"relationship\"<|>CANCER RESEARCH<|>NATIONAL CANCER INSTITUTE<|>Cancer Research is a journal that often publishes studies funded or conducted by the National Cancer Institute, indicating a strong relationship<|>9)\n##\n(\"relationship\"<|>CANCER EPIDEMIOLOGY BIOMARKERS AND PREVENTION<|>CANCER RESEARCH<|>Cancer Epidemiol Biomarkers Prev frequently publishes research findings that are also reported in Cancer Research, indicating a relationship<|>6)\n##\n(\"relationship\"<|>CANCER STATISTICS<|>NATIONAL CANCER INSTITUTE<|>Cancer Statistics is produced by the National Cancer Institute, establishing a direct relationship<|>10)\n##\n(\"relationship\"<|>LANCET<|>CANCER RESEARCH<|>The Lancet often publishes high-impact studies related to cancer that are also featured in Cancer Research, indicating a relationship<|>7)\n##\n(\"relationship\"<|>CANCER EPIDEMIOLOGY<|>CANCER CAUSES AND CONTROL<|>Cancer Epidemiology publishes studies that are often cited in Cancer Causes and Control, indicating a relationship<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 590-9.                                                            Intern Med. 2009;169:391-401.\n205.  Rhee MY, Kim JH, Kim YS, Chung JW, Bae JH, Nah                       217.   Ahearn TU, McCullough ML, Flanders WD, Long\n      DY, et al. High sodium intake in women with me-                             Q, Sidelnikov E, Fedirko V, et al. A randomized\n      tabolic syndrome. Korean Circ J. 2014;44:30-6.                              clinical trial of the effects of supplemental cal-\n206.   Johnson C, Raj TS, Trieu K, Arcand J, Wong MM,                             cium and vitamin D3 on markers of their meta-\n       McLean R, et al. The Science of Salt: A Systematic                         bolism in normal mucosa of colorectal adenoma\n       Review of Quality Clinical Salt Outcome Studies                            patients. Cancer Res. 2011;71:413-23.\n       June   2014     to   May     2015.    J   Clin   Hypertens          218.   Govers MJ, Van der Meet R. Effects of dietary cal-\n       (Greenwich). 2016;18:832-9.                                                cium and phosphate on the intestinal interac-\n207.   Sacks FM, Svetkey LP, Vollmer WM, Appel LJ,                                tions between calcium, phosphate, fatty acids,\n       Bray GA, Harsha D, et al. Effects on blood pressu-                         and bile acids. Gut. 1993;34:365-70.\n       re of reduced dietary sodium and the Dietary                        219.   McCullough ML, Rodriguez C, Diver WR, Feigel-\n       Approaches to Stop Hypertension (DASH) diet.                               son HS, Stevens VL, Thun MJ,             et al. Dairy, cal-\n       DASH-Sodium Collaborative Research Group. N                                cium, and vitamin D intake and postmenopausal\n       Engl J Med. 2001;344:3-10.                                                 breast cancer risk in the Cancer Prevention Study\n208.   Chen J, Gu D, Huang J, Rao DC, Jaquish CE, Hix-                            II Nutrition Cohort. Cancer Epidemiol Biomarkers\n       son JE, et al. Metabolic syndrome and salt sensi-                          Prev. 2005;14:2898-904.\n       tivity of blood pressure in non-diabetic people in                  220.   Hjartaker A, Thoresen M, Engeset D, Lund E.\n       China:    a   dietary   intervention      study.    Lancet.                Dairy consumption and calcium intake and risk of\n       2009;373:829-35.                                                           breast cancer in a prospective cohort: the Norwe-\n209.  Elwood PC, Pickering JE, Givens DI, Gallacher JE.                           gian Women and Cancer study. Cancer Causes\n      The consumption of milk and dairy foods and the                             Control. 2010;21:1875-85.\n      incidence of vascular disease and diabetes: an                       221.   Koralek DO, Bertone-Johnson ER, Leitzmann MF,\n      overview of the evidence. Lipids. 2010;45:925-39.                           Sturgeon SR, Lacey JV, Jr., Schairer C, et al. Rela-\n210.   Kondo I, Ojima T, Nakamura M, Hayasaka S, Ho-                              tionship between calcium, lactose, vitamin D,\n       zawa A, Saitoh S,       et al. Consumption of dairy                        and dairy products and ovarian cancer. Nutr Can-\n       products and death from cardiovascular disease                             cer. 2006;56:22-30.\n---\n  30    BLOQUE: DIETOTERAPIA\n\n\n\n222.  Parodi PW. A role for milk proteins and their pep-              235.  Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels\n      tides   in  cancer    prevention.      Curr    Pharm     Des.         A, Ward E, et al. Cancer statistics, 2004. CA Can-\n      2007;13:813-28.                                                       cer J Clin. 2004;54:8-29.\n223.  Gao X, LaValley MP, Tucker KL. Prospective stu-                 236.  Fedirko V, Riboli E, Tjonneland A, Ferrari P, Olsen\n      dies of dairy product and calcium intakes and                         A, Bueno-de-Mesquita HB,             et al. Prediagnostic\n      prostate cancer risk: a meta-analysis. J Natl Can-                    25-hydroxyvitamin D, VDR and CASR polymor-\n      cer Inst. 2005;97:1768-77.                                            phisms, and survival in patients with colorectal\n224.  Farlow DW, Xu X, Veenstra TD. Quantitative me-                        cancer in western European ppulations. Cancer\n      asurement of endogenous estrogen metabolites,                         Epidemiol Biomarkers Prev. 2012;21:582-93.\n      risk-factors for development of breast cancer, in               237.  Friedrich M, Rafi L, Mitschele T, Tilgen W, Schmidt\n      commercial milk products by LC-MS/MS. J Chro-                         W, Reichrath J. Analysis of the vitamin D system in\n      matogr      B\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}